Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1870 1
1906 1
1915 1
1916 2
1921 2
1923 2
1936 1
1939 1
1940 1
1947 1
1949 1
1952 1
1953 2
1954 3
1955 4
1956 3
1959 2
1960 1
1961 1
1962 2
1963 3
1964 2
1965 2
1966 1
1970 1
1972 2
1973 5
1974 8
1975 6
1976 3
1977 2
1978 1
1979 3
1980 6
1981 1
1982 2
1983 4
1984 2
1985 2
1986 1
1987 3
1988 12
1989 1
1990 2
1991 6
1992 2
1993 3
1994 2
1995 2
1996 5
1997 1
1998 1
1999 1
2000 7
2001 6
2002 3
2003 6
2004 6
2005 8
2006 10
2007 18
2008 13
2009 19
2010 17
2011 14
2012 20
2013 17
2014 26
2015 26
2016 25
2017 25
2018 59
2019 32
2020 17
2021 34
2022 25
2023 25
2024 25
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

597 results

Results by year

Filters applied: . Clear all
Page 1
Innate Immunity.
Kaur BP, Secord E. Kaur BP, et al. Immunol Allergy Clin North Am. 2021 Nov;41(4):535-541. doi: 10.1016/j.iac.2021.07.003. Immunol Allergy Clin North Am. 2021. PMID: 34602226 Review.
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584549 Clinical Trial.
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Clin Cancer Res. 2020 Aug 1;26(15):3928-3935. doi: 10.1158/1078-0432.CCR-20-0953. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601075 Free PMC article. Clinical Trial.
Innate Immunity.
Kaur BP, Secord E. Kaur BP, et al. Pediatr Clin North Am. 2019 Oct;66(5):905-911. doi: 10.1016/j.pcl.2019.06.011. Pediatr Clin North Am. 2019. PMID: 31466680 Review.
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Lee JM, Brady MF, Miller A, Moore RG, MacKay H, McNally L, Lea J, Street D, Lheureux S, McDonald ME, Duska LR, Cantuaria G, Kavecansky J, Leath CA 3rd, Powell M, Cadungog MG, Rose PG, Kim YM, Huang HQ, Provencher M, Wenzel LB, Bookman MA, Kohn EC, Secord AA. Lee JM, et al. J Clin Oncol. 2024 Dec 20;42(36):4305-4316. doi: 10.1200/JCO.24.00683. Epub 2024 Oct 3. J Clin Oncol. 2024. PMID: 39361946 Clinical Trial.
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14.
Brown J, Miller A, Holman LL, Backes F, Nagel C, Bender D, Miller DS, Powell MA, Westin SN, Bonebrake A, Muller CY, Secord AA, Crane E, Schorge J, Tew WP, Sood AK, Bookman MA, Aghajanian C, Gershenson DM. Brown J, et al. Gynecol Oncol. 2024 Nov;190:283-290. doi: 10.1016/j.ygyno.2024.09.002. Epub 2024 Sep 12. Gynecol Oncol. 2024. PMID: 39265466 Free PMC article. Clinical Trial.
Editorial: Women in pediatric immunology: 2021.
Secord E. Secord E. Front Pediatr. 2022 Sep 6;10:1013758. doi: 10.3389/fped.2022.1013758. eCollection 2022. Front Pediatr. 2022. PMID: 36147822 Free PMC article. No abstract available.
597 results